Thanks Rocky. Sounds like an efficacy possibility to me.
The stock is acting quite well.
Any thoughts on the timing and size of the next dilution? I assume they can currently fund these 12 patient trials. And if successful, they may see a very nice pop BEFORE any such offering. Thoughts appreciated. TIA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.